AKT1 and breast carcinoma: KAT7 overexpression enhances the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway, which is frequently dysregulated in breast cancer, promoting tumor growth, survival, and metabolism [157], and also contributes to radioresistance [110].